18.12.2008Wyeth Pharmaceuticals acquires Thiakis in a transaction worth up to £100m
Advent Venture Partners announces successful exit from portfolio company Thiakis in a transaction worth up to £100 million.
Press Release21.11.2008Infinity Pharmaceuticals strikes major alliance to fully fund promising pipelinePress Release
28.08.2008Algeta Reports Positive Headline Phase II Data on Pain Palliation with AlpharadinPress Release
21.02.2008Algeta receives IND Approval for Alpharadin(TM) to commence Clinical Development in the USAPress Release